Placental pathology and neonatal outcomes in pre-eclampsia with gestational diabetes mellitus

Abstract

Objective

To investigate histopathological placental lesions and adverse neonatal outcomes by Pre-eclampsia (PE) with Gestational Diabetes Mellitus (GDM).

Methods

This was a retrospective cohort study of pregnancies with PE delivered between 1 January 2012 to 1 January 2014. Pregnant women with PE were recruited, and divided into PE with GDM (PE + GDM) group (n = 278) and PE without GDM (PE − GDM) group (n = 586). We compared the placental pathology and neonatal outcomes between the two groups.

Results

The (PE + GDM) group was significantly associated with high placenta weight (534.8 ± 124.1 vs 519.3 ± 132.3 g, p = .011), the large diameter of the placenta (17.8 ± 2.2 vs 16.2 ± 2.7 cm, p = .016) than (PE − GDM) group. The incidence of chorioamnionitis in (PE + GDM) group was significantly higher than (PE − GDM) group [48.9% (136/278) vs 41.5% (243/586), p = .028], whereas there were no significant differences in umbilical cord length and infarction between the two groups. The (PE + GDM) group had a higher rate of prematurity [44.9% (125/278) vs 39.9% (234/586), p = .042] than (PE − GDM) group, in (PE + GDM) group the incidence of LGA [15.1% (42/278) vs 1.0% (6/586), p = .034], RDS [18.7% (52/278) vs 9.2% (54/586), p = .011] and hyperbilirubinemia [10.7% (30/278) vs 1.0% (6/586), p = .038] were higher than (PE − GDM) group.

Conclusions

GDM increased the offspring’s complication in pregnancy with PE, the potential mechanism might be that GDM increased the placenta inflammation.

Keywords:

• Gestational diabetes mellitus
• pre-eclampsia
• placental pathology
• neonatal outcomes

Disclosure statement

No potential conflict of interest was reported by the author(s).